Item Type | Name |
Academic Article
|
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
|
Academic Article
|
CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21.
|
Academic Article
|
Complement receptor 3 (CR3, Mac-1, integrin alpha M beta 2, CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils.
|
Academic Article
|
Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.
|
Academic Article
|
Moesin, and not the murine functional homologue (Crry/p65) of human membrane cofactor protein (CD46), is involved in the entry of measles virus (strain Edmonston) into susceptible murine cell lines.
|
Academic Article
|
Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.
|
Academic Article
|
Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis.
|
Academic Article
|
Induction of peri-insulitis but not diabetes in islet transplants expressing a single foreign antigen. A multi-stage model of disease.
|
Academic Article
|
Expression and function of membrane regulators of complement on rat astrocytes in culture.
|
Academic Article
|
The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.
|
Academic Article
|
Characterization of C3 receptors on cultured rat glomerular endothelial cells.
|
Academic Article
|
Characterization of C3-binding proteins on mouse neutrophils and platelets.
|
Academic Article
|
Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
|
Academic Article
|
EBV binds to lymphocytes of transgenic mice that express the human CR2 gene.
|
Academic Article
|
Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
|
Academic Article
|
Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways.
|
Academic Article
|
Genetics of the complement system and rheumatic diseases.
|
Academic Article
|
Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1.
|
Academic Article
|
Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules.
|
Academic Article
|
Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury.
|
Academic Article
|
Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus.
|
Academic Article
|
Expression of the murine complement regulatory protein crry by glial cells and neurons.
|
Academic Article
|
Phenotypes of complement knockouts.
|
Academic Article
|
Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure.
|
Academic Article
|
Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
|
Academic Article
|
Expression of functional human Epstein-Barr virus/C3d receptor ([CR2] CD21) on insulinoma cell line. Induction of tumor rejection but not diabetes in syngeneic rats.
|
Academic Article
|
Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein.
|
Academic Article
|
T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE).
|
Academic Article
|
Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.
|
Academic Article
|
The serum resistance of malaria-infected erythrocytes.
|
Academic Article
|
CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor.
|
Academic Article
|
Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
|
Academic Article
|
Arthritis critically dependent on innate immune system players.
|
Academic Article
|
Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs).
|
Academic Article
|
Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
|
Academic Article
|
Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.
|
Academic Article
|
The complement system as a therapeutic target in autoimmunity.
|
Academic Article
|
Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice.
|
Academic Article
|
Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.
|
Academic Article
|
Inhibition of complement activation decreases airway inflammation and hyperresponsiveness.
|
Academic Article
|
Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.
|
Academic Article
|
Activation of complement mediates antiphospholipid antibody-induced pregnancy loss.
|
Academic Article
|
Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
|
Academic Article
|
Complement activation is critical to airway hyperresponsiveness after acute ozone exposure.
|
Academic Article
|
Complement receptor 2 and autoimmunity.
|
Academic Article
|
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.
|
Academic Article
|
Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects.
|
Academic Article
|
Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis.
|
Academic Article
|
Complement receptors and the shaping of the natural antibody repertoire.
|
Academic Article
|
B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
|
Academic Article
|
Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice.
|
Academic Article
|
Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.
|
Academic Article
|
Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.
|
Academic Article
|
Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
|
Academic Article
|
Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation.
|
Academic Article
|
Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury.
|
Academic Article
|
Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.
|
Academic Article
|
Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
|
Academic Article
|
Polymorphisms of the regulators of complement activation gene cluster.
|
Academic Article
|
Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
|
Academic Article
|
Candidate inhibitors of porcine complement.
|
Academic Article
|
The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.
|
Academic Article
|
Role for CD21 in the establishment of an extracellular HIV reservoir in lymphoid tissues.
|
Academic Article
|
Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway.
|
Academic Article
|
Complement is an essential component of the immune response to adeno-associated virus vectors.
|
Academic Article
|
Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia.
|
Academic Article
|
Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.
|
Academic Article
|
Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
|
Academic Article
|
The spectrum of complement alternative pathway-mediated diseases.
|
Academic Article
|
Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies.
|
Academic Article
|
Complement activation fragment Bb in early pregnancy and spontaneous preterm birth.
|
Academic Article
|
A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
|
Academic Article
|
Solution structure of the complex formed between human complement C3d and full-length complement receptor type 2.
|
Academic Article
|
Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.
|
Academic Article
|
Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.
|
Academic Article
|
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.
|
Academic Article
|
The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1.
|
Academic Article
|
Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.
|
Academic Article
|
Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.
|
Academic Article
|
Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro.
|
Academic Article
|
Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.
|
Academic Article
|
Aseptic injury to epithelial cells alters cell surface complement regulation in a tissue specific fashion.
|
Academic Article
|
Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair.
|
Academic Article
|
The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.
|
Academic Article
|
Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
|
Academic Article
|
Complement receptors.
|
Academic Article
|
Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.
|
Academic Article
|
The regulators of complement activation (RCA) gene cluster.
|
Academic Article
|
Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
|
Academic Article
|
Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.
|
Academic Article
|
Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli.
|
Academic Article
|
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases.
|
Academic Article
|
Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.
|
Academic Article
|
CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants.
|
Academic Article
|
Identification of a central role for complement in osteoarthritis.
|
Academic Article
|
Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.
|
Academic Article
|
Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.
|
Academic Article
|
Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice.
|
Academic Article
|
Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
|
Academic Article
|
Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d.
|
Academic Article
|
The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment.
|
Academic Article
|
Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.
|
Academic Article
|
Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
|
Academic Article
|
IgM contributes to glomerular injury in FSGS.
|
Academic Article
|
Identification of a third component of complement-binding glycoprotein of human platelets.
|
Academic Article
|
Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice.
|
Academic Article
|
Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.
|
Academic Article
|
Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis.
|
Academic Article
|
Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation.
|
Academic Article
|
Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
|
Academic Article
|
Mouse complement receptor-related gene y/p65-neutralized tumor vaccine induces antitumor activity in vivo.
|
Academic Article
|
Mouse Crry/p65 is a regulator of the alternative pathway of complement activation.
|
Academic Article
|
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.
|
Academic Article
|
CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
|
Academic Article
|
Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
|
Academic Article
|
CD21 augments antigen presentation in immune individuals.
|
Academic Article
|
Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.
|
Academic Article
|
Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study.
|
Academic Article
|
Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway.
|
Academic Article
|
Complement component c5a is integral to the febrile response of mice to lipopolysaccharide.
|
Academic Article
|
An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.
|
Academic Article
|
Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response.
|
Academic Article
|
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
|
Academic Article
|
Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
|
Academic Article
|
The structure of human CD23 and its interactions with IgE and CD21.
|
Academic Article
|
A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model.
|
Academic Article
|
The central role of the alternative complement pathway in human disease.
|
Academic Article
|
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.
|
Academic Article
|
A critical role for murine complement regulator crry in fetomaternal tolerance.
|
Academic Article
|
Complement receptors.
|
Academic Article
|
Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.
|
Academic Article
|
Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure.
|
Academic Article
|
Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation.
|
Academic Article
|
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
|
Academic Article
|
The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions.
|
Academic Article
|
A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation.
|
Academic Article
|
Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
|
Academic Article
|
Structure of the Epstein-Barr virus major envelope glycoprotein.
|
Academic Article
|
A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2.
|
Academic Article
|
Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
|
Academic Article
|
Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
|
Academic Article
|
Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire.
|
Academic Article
|
The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
|
Academic Article
|
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.
|
Academic Article
|
Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
|
Academic Article
|
The alternative pathway of complement in disease: opportunities for therapeutic targeting.
|
Academic Article
|
CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE.
|
Academic Article
|
Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.
|
Academic Article
|
Acute tubular necrosis is characterized by activation of the alternative pathway of complement.
|
Academic Article
|
The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy.
|
Academic Article
|
A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
|
Academic Article
|
Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation.
|
Academic Article
|
Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350.
|
Academic Article
|
C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion.
|
Academic Article
|
Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.
|
Academic Article
|
Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
|
Academic Article
|
Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice.
|
Academic Article
|
Cutting edge: Complement (C3d)-linked antigens break B cell anergy.
|
Academic Article
|
Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21).
|
Academic Article
|
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
|
Academic Article
|
The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia.
|
Academic Article
|
Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3' end of the C3b/C4b receptor gene.
|
Academic Article
|
Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).
|
Academic Article
|
Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.
|
Academic Article
|
Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
|
Academic Article
|
A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
|
Academic Article
|
Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
|
Academic Article
|
A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.
|
Academic Article
|
B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion.
|
Academic Article
|
Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis.
|
Academic Article
|
Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.
|
Academic Article
|
Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor.
|
Academic Article
|
Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes.
|
Academic Article
|
The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.
|
Academic Article
|
The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation.
|
Academic Article
|
Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.
|
Academic Article
|
Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia.
|
Academic Article
|
CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation.
|
Academic Article
|
The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus.
|
Academic Article
|
Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1.
|
Academic Article
|
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
|
Academic Article
|
Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.
|
Academic Article
|
Challenging the role of adaptive immunity in neurotrauma: Rag1(-/-) mice lacking mature B and T cells do not show neuroprotection after closed head injury.
|
Academic Article
|
Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis.
|
Academic Article
|
Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE).
|
Academic Article
|
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.
|
Academic Article
|
Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.
|
Academic Article
|
Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.
|
Academic Article
|
Detection of complement activation using monoclonal antibodies against C3d.
|
Academic Article
|
Analysis of C3b/C4b receptor (CR1) polymorphic variants by tryptic peptide mapping.
|
Academic Article
|
Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.
|
Academic Article
|
Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.
|
Concept
|
Complement Inactivating Agents
|
Concept
|
Complement C4
|
Concept
|
Complement C3 Convertase, Alternative Pathway
|
Concept
|
Receptors, Complement 3b
|
Concept
|
Complement Activating Enzymes
|
Concept
|
Complement C5a
|
Concept
|
Complement C3b Inactivator Proteins
|
Concept
|
Complement C4a
|
Concept
|
Complement Membrane Attack Complex
|
Concept
|
Complement C4b-Binding Protein
|
Concept
|
Complement Factor I
|
Concept
|
Complement C9
|
Concept
|
Complement Factor B
|
Concept
|
Complement C3-C5 Convertases
|
Concept
|
Complement C3b
|
Concept
|
Complement Pathway, Classical
|
Concept
|
Complement Pathway, Mannose-Binding Lectin
|
Concept
|
Complement C3a
|
Concept
|
Complement Activation
|
Concept
|
Complement Pathway, Alternative
|
Concept
|
Complement C1q
|
Concept
|
Complement Factor D
|
Concept
|
Complement C4b
|
Concept
|
Complement Factor H
|
Concept
|
Complement C5b
|
Concept
|
Receptors, Complement 3d
|
Concept
|
Complement Inactivator Proteins
|
Concept
|
Complement C5
|
Concept
|
Complement C3
|
Concept
|
Complement C6
|
Concept
|
Complement System Proteins
|
Concept
|
Receptors, Complement
|
Concept
|
Complement C8
|
Concept
|
Complement C3d
|
Academic Article
|
Human C3 glomerulopathy provides unique insights into complement factor H-related protein function.
|
Academic Article
|
Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura.
|
Academic Article
|
C3 glomerulopathy: consensus report.
|
Academic Article
|
Complement and its receptors: new insights into human disease.
|
Academic Article
|
Deficiency of complement receptors CR2/CR1 in Cr2?/? mice reduces the extent of secondary brain damage after closed head injury.
|
Academic Article
|
Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.
|
Academic Article
|
Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
|
Academic Article
|
Clinical utility of complement biomarkers in the diagnosis and treatment of acute thrombotic microangiopathies.
|
Academic Article
|
A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
|
Academic Article
|
Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
|
Academic Article
|
A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.
|
Academic Article
|
Analysis of tandem E-box motifs within human Complement receptor 2 (CR2/CD21) promoter reveals cell specific roles for RP58, E2A, USF and localized chromatin accessibility.
|
Academic Article
|
IgM exacerbates glomerular disease progression in complement-induced glomerulopathy.
|
Academic Article
|
Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.
|
Academic Article
|
Annexin A2 Enhances Complement Activation by Inhibiting Factor H.
|
Academic Article
|
The Relationship of Longitudinal Levels of Complement Bb During Pregnancy with Preeclampsia.
|
Academic Article
|
Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains.
|
Academic Article
|
Targeting mechanisms at sites of complement activation for imaging and therapy.
|
Academic Article
|
Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.
|
Academic Article
|
New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.
|
Academic Article
|
Mannan-Binding Lectin-Associated Serine Protease 1/3 Cleavage of Pro-Factor D into Factor D In Vivo and Attenuation of Collagen Antibody-Induced Arthritis through Their Targeted Inhibition by RNA Interference-Mediated Gene Silencing.
|
Academic Article
|
Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.
|
Academic Article
|
Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
|
Academic Article
|
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.
|
Academic Article
|
Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.
|
Academic Article
|
In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms.
|
Grant
|
Mouse Membrane RCA Proteins in the Immune Response
|
Grant
|
C3d/EBV Receptor Ligand Binding Sites
|
Grant
|
Disconnecting CR2/CD21 from Its C3d Ligand to Ameliorate Lupus
|
Grant
|
Complement in the Pathogenesis of Autoimmune Arthritis
|
Grant
|
Denver Autoimmunity Center of Excellence
|
Academic Article
|
Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.
|
Academic Article
|
Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2.
|
Academic Article
|
The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.
|
Academic Article
|
A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice.
|
Academic Article
|
Modulation of the Alternative Pathway of Complement by Murine Factor H-Related Proteins.
|
Academic Article
|
Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.
|
Academic Article
|
The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.
|
Academic Article
|
Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
|
Academic Article
|
Complement in the Initiation and Evolution of Rheumatoid Arthritis.
|
Academic Article
|
Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.
|
Academic Article
|
Preface to the Special issue for the 27th International complement workshop.
|
Academic Article
|
Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.
|
Academic Article
|
Systemic activation of the complement system in patients with advanced age-related macular degeneration.
|
Academic Article
|
Complement and its environmental determinants in the progression of human rheumatoid arthritis.
|
Academic Article
|
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.
|
Academic Article
|
Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.
|
Academic Article
|
Key Components of the Complement Lectin Pathway Are Not Only Required for the Development of Inflammatory Arthritis but Also Regulate the Transcription of Factor D.
|
Academic Article
|
Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging.
|
Academic Article
|
Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy.
|
Grant
|
Complement in the Pathogenesis of Autoimmune Arthritis
|
Academic Article
|
C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
|
Academic Article
|
A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury.
|
Academic Article
|
Complement component factor B has thrombin-like activity.
|
Academic Article
|
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
|
Academic Article
|
Insights Into the Structure-Function Relationships of Dimeric C3d Fragments.
|
Academic Article
|
Elevated plasma complement components in facioscapulohumeral dystrophy.
|
Academic Article
|
A Potential New Mouse Model of Axial Spondyloarthritis Involving the Complement System.
|
Academic Article
|
Marginal zone B cells acquire dendritic cell functions by trogocytosis.
|
Academic Article
|
Correlation of Complement Activation in Aqueous and Vitreous in Patients With Proliferative Diabetic Retinopathy.
|
Academic Article
|
Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features.
|
Academic Article
|
Sex and Age-Related Differences in Complement Factors Among Patients With Intermediate Age-Related Macular Degeneration.
|
Academic Article
|
Development and Optimization of Bifunctional Fusion Proteins to Locally Modulate Complement Activation in Diseased Tissue.
|
Academic Article
|
Factor H related proteins modulate complement activation on kidney cells.
|
Academic Article
|
Complement: The Road Less Traveled.
|
Academic Article
|
Contributions of animal models to mechanistic understandings of antibody-dependent disease and roles of the amplification loop.
|
Academic Article
|
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response.
|
Academic Article
|
Noninvasive Detection of iC3b/C3d Deposits in the Kidney Using a Novel Bioluminescent Imaging Probe.
|
Academic Article
|
Potential causal role of synovial complement system activation in the development of post-traumatic osteoarthritis after anterior cruciate ligament injury or meniscus tear.
|
Academic Article
|
Complement therapeutics are coming of age in rheumatology.
|
Academic Article
|
Decrease in multiple complement protein levels is associated with the development of islet autoimmunity and type 1 diabetes.
|
Academic Article
|
Genetic variants in the complement system and their potential link in the aetiology of type 1 diabetes.
|
Academic Article
|
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response.
|
Academic Article
|
Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins.
|